We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

FLT3 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant human FLT3 (571–993) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. FLT3 is a receptor tyrosine kinase that has been shown to play a role in proliferation and survival of hematopoietic progenitor cells as well as differentiation of early B lymphoid progenitors (1). FLT3 consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. FLT3 is the most frequently mutated gene in cases of acute myelogenous leukemia (AML)....

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart
FLT3 Kinase Enzyme System
Close Window

FLT3 Kinase Enzyme System  Components

10μg
- V4064 $ 406.00 Add to cart

FLT3 Kinase Enzyme System

Close Window

FLT3 Kinase Enzyme System

 Components

1mg
- V6394 $ 5,990.00 Add to cart
ADP-Glo™ Kinase Assay + FLT3 Kinase Enzyme System
Close Window

ADP-Glo™ Kinase Assay + FLT3 Kinase Enzyme System  Components

  • FLT3 Kinase Enzyme System

    V40641 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V4065 $ 808.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V4064, V6394, V4065 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V4065 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V4065 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V4065 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V4065 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V4065 U.S. Pat. No. 8,183,007 and other patents pending.

V4065 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V4065 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.